Drug Therapy

Benzoyl Peroxide Cleansers for the Treatment of Acne Vulgaris: Status Report on Available Data

Benzoyl peroxide (BPO) cleansers are commonly prescribed for treatment of acne vulgaris. In fact, they represent approximately half of all BPO prescriptions from dermatology practices. Data are limited on the ability of BPO cleansers to reduce counts of Propionibacterium acnes, impact on reduction and emergence of antibiotic-resistant P acnes strains, and efficacy for facial and truncal acne vulgaris. This article discusses available data on BPO cleanser formulations.


 

Recommended Reading

Device Uses Light, Vacuum To Improve Acne Lesions
MDedge Dermatology
Acne Treatments Reviewed, Starting With Touch
MDedge Dermatology
Superficial Chemical Peels and Microdermabrasion for Acne Vulgaris
MDedge Dermatology
Evidence for Laser- and Light-Based Treatment of Acne Vulgaris
MDedge Dermatology
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
MDedge Dermatology
A Novel Gel Formulation of Clindamycin Phosphate–Tretinoin Is Not Associated With Acne Flaring
MDedge Dermatology
Levonorgestrel-Releasing Intrauterine System and New-Onset Acne [letter]
MDedge Dermatology
The Effect of Vehicle Formulation on Acne Medication Tolerability
MDedge Dermatology
Acne and Rosacea: Who and Where Are the Experts? [editorial]
MDedge Dermatology
Clinical Implications of Minocycline Use in Acne Vulgaris: Focus on Antimicrobial and Anti-inflammatory Properties
MDedge Dermatology